Gaviscon advance

BNF:: GI system
Status:: Grey
Decision Date:: February 2023

Comments

Only after formulary choice Acidex advance is thought to be inappropriate due intolerance or inadequate symptom control.

Brown Drug Classifications

5: Less cost-effective than current standard therapy